CRISPR/dCas9技术在基因表达调控中的研究进展

doi:10.16431/j.cnki.1671-7236.2022.01.006

摘要/Abstract

摘要： CRISPR/dCas9是在CRISPR/Cas9基因编辑系统的基础上改造升级建立起的一种用于调控基因组转录与表观遗传修饰的系统，它不仅继承了CRISPR/Cas9系统的精准性，同时还展现出了良好的作用效果。在该系统中dCas9蛋白保留了Cas9蛋白结合DNA的能力而切割功能不复存在。将dCas9蛋白与不同的激活、抑制效应子域和表观遗传调控酶偶联，可以对基因表达与表观遗传修饰进行精确调控。组蛋白乙酰化、组蛋白甲基化、DNA甲基化等表观遗传修饰过程是基因表达的基础，对整个生命过程作出了巨大的贡献，同时表观遗传与多种疾病和癌症都存在因果关系，因此以CRISPR/dCas9系统为框架的不同表观遗传修饰系统在人类疾病治疗和癌症研究领域具有重要的研究价值。笔者简要介绍了CRISPR/Cas9系统的发现过程以及作用原理，主要总结了以CRISPR/dCas9系统为框架的不同调控系统在基因表达调控和表观遗传调控中的应用以及优化过程，以期为从事相关领域的科研工作者提供一些参考。

关键词: CRISPR/Cas9; dCas9; 激活; 抑制; 表观遗传修饰

Abstract: CRISPR/dCas9 is a system for regulating genome transcription and epigenetic modification based on the transformation and upgrading of the CRISPR/Cas9 gene editing system. It not only inherits the target accuracy of the CRISPR/Cas9 system, at the same time, it also showed a good effect. In this system, the dCas9 protein retains the ability of the Cas9 protein to bind DNA and the cleavage function no longer exists. Coupling dCas9 protein with different activation and inhibitory effector domains and epigenetic regulation enzymes makes it possible to precisely regulate gene expression and epigenetic modification. Epigenetic modification processes such as histone acetylation, histone methylation and DNA methylation are the basis of gene expression and have made a huge contribution to the entire life process. At the same time, epigenetics is causally related to many diseases and cancers. Different epigenetic modification systems based on the CRISPR/dCas9 system have unlimited future and research value in the field of human disease treatment and cancer research. Therefore, this article briefly introduces the discovery process and the principle of action of the CRISPR/Cas9 system. It mainly summarizes the application and optimization process of different regulatory systems based on the CRISPR/dCas9 system in the regulation of gene expression and epigenetic regulation. It hopes to provide some references for scientific research workers engaged in related fields.

Key words: CRISPR/Cas9; dCas9; activation; interference; epigenetic modification

中图分类号:

杨莎, 郝海生, 杜卫华, 庞云渭, 赵善江, 邹惠影, 朱化彬, 杨宇泽, 赵学明. CRISPR/dCas9技术在基因表达调控中的研究进展[J]. 中国畜牧兽医, 2022, 49(1): 53-59.

YANG Sha, HAO Haisheng, DU Weihua, PANG Yunwei, ZHAO Shanjiang, ZOU Huiying, ZHU Huabin, YANG Yuze, ZHAO Xueming. Research Progress of CRISPR/dCas9 Technology in Gene Expression Regulation[J]. China Animal Husbandry and Veterinary Medicine, 2022, 49(1): 53-59.

参考文献

[1] GASIUNAS G,BARRANGOU R,HORVATH P,et al.Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria[J].Proceedings of the National Academy of Sciences of the United States of America,2012,109(39):E2579-E2586.
[2] ISHINO Y,SHINAGAWA H,MAKINO K,et al.Nucleotide sequence of the iap gene,responsible for alkaline phosphatase isozyme conversion in Escherichia coli,and identification of the gene product[J].Journal of Bacteriology,1987,169(12):5429-5433.
[3] SHMAKOV S,SMARGON A,SCOTT D,et al.Diversity and evolution of class 2 CRISPR-Cas systems[J].Nature Reviews.Microbiology,2017,15(3):169-182.
[4] BHAYA D,DAVISON M,BARRANGOU R.CRISPR-Cas systems in bacteria and archaea:Versatile small RNAs for adaptive defense and regulation[J].Annual Review of Genetics,2011,45:273-297.
[5] JINEK M,CHYLINSKI K,FONFARA I,et al.A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity[J].Science,2012,337(6096):816-821.
[6] CONG L,RAN F A,COX D,et al.Multiplex genome engineering using CRISPR/Cas systems[J].Science,2013,339(6121):819-823.
[7] JINEK M,JIANG F,TAYLOR D W,et al.Structures of Cas9 endonucleases reveal RNA-mediated conformational activation[J].Science,2014,343(6176):1247997.
[8] NISHIMASU H,CONG L,YAN W X,et al.Crystal structure of Staphylococcus aureus Cas9[J].Cell,2015,162(5):1113-1126.
[9] STERNBERG S H,REDDING S,JINEK M,et al.DNA interrogation by the CRISPR RNA-guided endonuclease Cas9[J].Nature,2014,507(7490):62-67.
[10] NIU Y,SHEN B,CUI Y,et al.Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos[J].Cell,2014,156(4):836-843.
[11] BARMAN A,DEB B,CHAKRABORTY S.A glance at genome editing with CRISPR-Cas9 technology[J].Current Genetics,2020,66(3):447-462.
[12] WYMAN C,KANAAR R.DNA double-strand break repair:All's well that ends well[J].Annual Review of Genetics,2006,40:363-383.
[13] QI L S,LARSON M H,GILBERT L A,et al.Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression[J].Cell,2013,152(5):1173-1183.
[14] MORADPOUR M, ABDULAH S N A.CRISPR/dCas9 platforms in plants:Strategies and applications beyond genome editing[J].Plant Biotechnology Journal,2020,18(1):32-44.
[15] PICKAR-OLIVER A,GERSBACH C A.The next generation of CRISPR-Cas technologies and applications[J].Nature Reviews.Molecular Cell Biology,2019,20(8):490-507.
[16] MAKAROVA K S,HAFT D H,BARRANGOU R,et al.Evolution and classification of the CRISPR-Cas systems[J].Nature Reviews.Microbiology,2011,9(6):467-477.
[17] MCCARTY N S,GRAHAM A E,STUDENÁ L,et al.Multiplexed CRISPR technologies for gene editing and transcriptional regulation[J].Nature Communications,2020,11(1):1281.
[18] PEREZ-PINERA P,KOCAK D D,VOCKLEY C M,et al.RNA-guided gene activation by CRISPR-Cas9-based transcription factors[J].Nature Methods,2013,10(10):973-976.
[19] MAEDER M L,LINDER S J,CASCIO V M,et al.CRISPR RNA-guided activation of endogenous human genes[J].Nature Methods,2013,10(10):977-979.
[20] THAKORE P I,BLACK J B,HILTON I B,et al.Editing the epigenome:Technologies for programmable transcription and epigenetic modulation[J].Nature Methods,2016,13(2):127-137.
[21] MAROUFI F,MAALI A,ABDOLLAHPOUR-ALITAPPEH M,et al.CRISPR-mediated modification of DNA methylation pattern in the new era of cancer therapy[J].Epigenomics,2020,12(20):1845-1859.
[22] TANENBAUM M E,GILBERT L A,QI L S,et al.A protein-tagging system for signal amplification in gene expression and fluorescence imaging[J].Cell,2014,159(3):635-646.
[23] CHAVEZ A,SCHEIMAN J,VORA S,et al.Highly efficient Cas9-mediated transcriptional programming[J].Nature Methods,2015,12(4):326-328.
[24] KONERMANN S,BRIGHAM M D,TREVINO A E,et al.Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex[J].Nature,2015,517(7536):583-588.
[25] BIKARD D,JIANG W,SAMAI P,et al.Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system[J].Nucleic Acids Research,2013,41(15):7429-7437.
[26] DOMINGUEZ A A,LIM W A,QI L S.Beyond editing:Repurposing CRISPR-Cas9 for precision genome regulation and interrogation[J].Nature Reviews.Molecular Cell Biology,2016,17(1):5-15.
[27] GILBERT L A,LARSON M H,MORSUT L,et al.CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes[J].Cell,2013,154(2):442-451.
[28] GAO X,TSANG J C H,GABA F,et al.Comparison of TALE designer transcription factors and the CRISPR/dCas9 in regulation of gene expression by targeting enhancers[J].Nucleic Acids Research,2014,42(20):e155.
[29] KEARNS N A,PHAM H,TABAK B,et al.Functional annotation of native enhancers with a Cas9-histone demethylase fusion[J].Nature Methods,2015,12(5):401-403.
[30] THAKORE P I,D'IPPOLITO A M,SONG L,et al.Highly specific epigenome editing by CRISPR-Cas9 repressors for silencing of distal regulatory elements[J].Nature Methods,2015,12(12):1143-1149.
[31] AMABILE A,MIGLIARA A,CAPASSO P,et al.Inheritable silencing of endogenous genes by hit-and-run targeted epigenetic editing[J].Cell,2016,167(1):219-232.
[32] YEO N C,CHAVEZ A,LANCE-BYRNE A,et al.An enhanced CRISPR repressor for targeted mammalian gene regulation[J].Nature Methods,2018,15(8):611-616.
[33] ALERASOOL N,SEGAL D,LEE H,et al.An efficient KRAB domain for CRISPRi applications in human cells[J].Nature Methods,2020,17(11):1093-1096.
[34] WOLFFE A P,MATZKE M A.Epigenetics:Regulation through repression[J].Science,1999,286(5439):481-486.
[35] LAPRISE S L.Implications of epigenetics and genomic imprinting in assisted reproductive technologies[J].Molecular Reproduction and Development,2009,76(11):1006-1018.
[36] TUCCI V,ISLES A R,KELSEY G,et al.Genomic imprinting and physiological processes in mammals[J].Cell,2019,176(5):952-965.
[37] 孔康杰,倪颖勤.表观遗传学修饰对小胶质细胞功能调控的研究进展[J].中国眼耳鼻喉科杂志,2021,21(1):60-64. KONG K J,NI Y Q.Research progress in epigenetic modifications regulating functions of microglia[J].Chinese Journal of Ophthalmology and Otolaryngology,2021,21(1):60-64.(in Chinese)
[38] LI B,CAREY M,WORKMAN J L.The role of chromatin during transcription[J].Cell,2007,128(4):707-719.
[39] HILTON I B,D'IPPOLITO A M,VOCKLEY C M,et al.Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers[J].Nature Biotechnology,2015,33(5):510-517.
[40] BOHNSACK J P,PATEL V K,MORROW A L.Ethanol exposure regulates expression via histone deacetylation at the promoter in cultured cortical neurons[J].The Journal of Pharmacology and Experimental Therapeutics,2017,363(1):1-11.
[41] KWON D Y,ZHAO Y-T,LAMONICA J M,et al.Locus-specific histone deacetylation using a synthetic CRISPR-Cas9-based HDAC[J].Nature Communications,2017,8:15315.
[42] LIU J,SUN M,CHO K B,et al.A CRISPR-Cas9 repressor for epigenetic silencing of KRAS[J].Pharmacological Research,2021,164:105304.
[43] CHEN X,WEI M,LIU X,et al.Construction and validation of the CRISPR/dCas9-EZH2 system for targeted H3K27Me3 modification[J].Biochemical and Biophysical Research Communications,2019,511(2):246-252.
[44] FUKUSHIMA H S,TAKEDA H,NAKAMURA R.Targeted in vivo epigenome editing of H3K27me3[J].Epigenetics & Chromatin,2019,12(1):17.
[45] GUHATHAKURTA S,KIM J,ADAMS L,et al.Targeted attenuation of elevated histone marks at SNCA alleviates α-synuclein in Parkinson's disease[J].EMBO Molecular Medicine,2021,13(2):e12188.
[46] BIRD A.DNA methylation patterns and epigenetic memory[J].Genes & Development,2002,16(1):6-21.
[47] ADAMS R L.Eukaryotic DNA methyltransferases——Structure and function[J].BioEssays,1995,17(2):139-145.
[48] JONES P A,BAYLIN S B.The fundamental role of epigenetic events in cancer[J].Nature Reviews.Genetics,2002,3(6):415-428.
[49] WALSH C P,CHAILLET J R,BESTOR T H.Transcription of IAP endogenous retroviruses is constrained by cytosine methylation[J].Nature Genetics,1998,20(2):116-117.
[50] VERTINO P M,SEKOWSKI J A,COLL J M,et al.DNMT1 is a component of a multiprotein DNA replication complex[J].Cell Cycle,2002,1(6):416-423.
[51] OKANO M,BELL D W,HABER D A,et al.DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development[J].Cell,1999,99(3):247-257.
[52] MCDONALD J I,CELIK H,ROIS L E,et al.Reprogrammable CRISPR/Cas9-based system for inducing site-specific DNA methylation[J].Biology Open,2016,5(6):866-874.
[53] VOJTA A,DOBRINIĆ P,TADIĆ V,et al.Repurposing the CRISPR-Cas9 system for targeted DNA methylation[J].Nucleic Acids Research,2016,44(12):5615-5628.
[54] LIU X S,WU H,JI X,et al.Editing DNA methylation in the mammalian genome[J].Cell,2016,167(1):233-247.
[55] WEI Y,LANG J,ZHANG Q,et al.DNA methylation analysis and editing in single mammalian oocytes[J].Proceedings of the National Academy of Sciences of the United States of America,2019,116(20):9883-9892.
[56] MORITA S,NOGUCHI H,HORII T,et al.Targeted DNA demethylation in vivo using dCas9-peptide repeat and scFv-TET1 catalytic domain fusions[J].Nature Biotechnology,2016,34(10):1060-1065.
[57] HUANG Y-H,SU J,LEI Y,et al.DNA epigenome editing using CRISPR-Cas SunTag-directed DNMT3A[J].Genome Biology,2017,18(1):176.
[58] PFLUEGER C,TAN D,SWAIN T,et al.A modular dCas9-SunTag DNMT3A epigenome editing system overcomes pervasive off-target activity of direct fusion dCas9-DNMT3A constructs[J].Genome Research,2018,28(8):1193-1206.
[59] STEPPER P,KUNGULOVSKI G,JURKOWSKA R Z,et al.Efficient targeted DNA methylation with chimeric dCas9-Dnmt3a-Dnmt3l methyltransferase[J].Nucleic Acids Research,2017,45(4):1703-1713.
[60] WU H,ZHANG Y.Reversing DNA methylation:Mechanisms,genomics,and biological functions[J].Cell,2014,156(1-2):45-68.
[61] LIU X S,WU H,KRZISCH M,et al.Rescue of fragile X syndrome neurons by DNA methylation editing of the FMR1 gene[J].Cell,2018,172(5):979-992.
[62] XU X,TAO Y,GAO X,et al.A CRISPR-based approach for targeted DNA demethylation[J].Cell Discovery,2016,2:16009.
[63] XU X,TAN X,TAMPE B,et al.High-fidelity CRISPR/Cas9-based gene-specific hydroxymethylation rescues gene expression and attenuates renal fibrosis[J].Nature Communications,2018,9(1):3509.